The FDA has accepted Aquestive Therapeutics’ new drug application for its Anaphylm sublingual epinephrine film for treating ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

In myasthenia gravis, complement plays a big role in what happens to the muscle end of the neuromuscular junction, explains ...

Discover a study that calls for more longitudinal research and encouragement for clinicians to screen for mental health symptoms in patients with allergic rhinitis.

This Research Topic is the second volume of the “Exploring Immunological Tolerance in Allergy Treatment through AIT” Community Series. Please see Volume I ...

About 17% of kids are admitted for overnight observation following a scary allergic reaction to food, medicine or insect ...

The struggle is real,” says Nikki Chaffin, a resident from Elkhart who says her family has a lot of allergies, and are ...

Summer is the season of gardening, but with that comes allergies. If you need to do yard work but your allergies are making ...

Immunotherapy. 2012;4(6):601-616. There is no allergic basis for the majority of chronic urticaria and angioedema patients or clinical trial evidence to support treatment of these conditions with ...

In 2021, more than 25% of kids in the United States were reported to have some sort of allergy. These allergies usually show up in infancy or childhood. Allergies can get in the way of your child ...

Monascin, a natural and safe drug, exhibits potent anti-inflammatory, hypolipidemic, and antioxidative effects. However, their therapeutic potential and underlying mechanisms in allergic rhinitis (AR) ...